Sunday, September 17, 2017

Pharma Reviews: Fosun Group injects new life into Gland Pharma deal

Fosun Pharma said it would spend no more than $25 million for the Indian firm's Enoxaparin prototype sales in the US, when it gets approval there, ...
Read more: Fosun Group injects new life into Gland Pharma deal